跳至主要内容
临床试验/NCT01968408
NCT01968408已完成3 期

Effectiveness of Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children: a Randomized, Double-blind Placebo Controlled Trial

Medical University of Warsaw2 个研究点 分布在 1 个国家目标入组 184 人开始时间: 2012年9月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
184
试验地点
2
主要终点
Incidence of nosocomial diarrhea (defined as the passage of 3 or more loose or watery stools in a 24-hour period that will occur more than 72 hours after admission)

研究概览

简要总结

AIM: To determine the efficacy of Lactobacillus reuteri DSM 17938 at a dose of 10(9) CFU for the prevention of nosocomial diarrhea.

TRIAL DESIGN: Double-blind, placebo controlled RCT. INTERVENTION: L reuteri DSM 17938 in a daily dose of 10(9) CFU. PRIMARY OUTCOME: Nosocomial diarrhoea (3 or more loose or watery stools in a 24 h that will occur more than 72 h after admission).

详细描述

Nosocomial diarrhea is a common problem in hospitalized children. Previously, it has been documented that the administration of L reuteri DSM 17938 at a dose of 10(8) colony forming units (CFU) compared with placebo had no effect on the overall incidence of nosocomial diarrhea (Wanke & Szajewska, J Pediatr 2012). Whether higher doses of L reuteri DSM 17938 have such effects needs to be substantiated in further randomized trials.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Month 至 48 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 1-48 mo admitted to the hospital for reasons other than diarrhea
  • Signed informed consent.

排除标准

  • Acute gastroenteritis within 3 days before admission
  • Symptoms other than diarrhea suggesting gastroenteritis
  • Use of probiotics within 7 days before admission
  • Immunodeficiency disorders
  • Breastfeeding >50%
  • Underlying gastrointestinal tract disorder
  • Malnutrition (weight/high <3pc)

结局指标

主要结局

Incidence of nosocomial diarrhea (defined as the passage of 3 or more loose or watery stools in a 24-hour period that will occur more than 72 hours after admission)

时间窗: Any time starting 72 h after admission

次要结局

  • Incidence of rotavirus diarrhea (ie, detection of rotavirus or antigen in the stools)(72 hours after admission to the hospital to 72 hours after discharge)
  • Adverse effects(During hospitalisation (expected average 3-5 days) plus 72 h after discharge)
  • Incidence of diarrhea- passage of 3 or more loose or watery stools in a 24-h period(from the time of admission to the time of discharge of the hospital-expected average 3-5 days)
  • Duration of diarrhea (ie, time till the last loose or watery stool from the onset of diarrhea)(during hospitalisation (expected average 3-5 days) and 72 h after discharge)
  • Need and the length of intravenous rehydration due to diarrhea(During the hospitalization-expected average 3-5 days)
  • Prolongation of the hospitalization due to nosocomial diarrhea(during the hospitalization-expected average 3-5 days)
  • Incidence of chronic diarrhea- lasting more than 14 days(untill 14 days after onset of diarrhea)
  • Length of hospital stay(During hospitalisation-expected average 3-5 days)

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hanna Szajewska

Proffesor

Medical University of Warsaw

研究点 (2)

Loading locations...

相似试验